Bangkok Genomics Innovation PCLBKK:BKGI -2.88%45 Dividend Yield % is 2.48% as of Jun. 28, 2026, which is 28% below its 10-year median of 3.46. GuruFocus rates BKK:BKGI with a GF Score™ of 45/100. The stock has 12 warning signs investors should review. Among 65 Medical Diagnostics & Research companies, Bangkok Genomics Innovation PCL ranks better than 60% on this metric.
Bangkok Genomics Innovation PCL stock Dividend Yield % is close to 1-year low.
The historical rank and industry rank for Bangkok Genomics Innovation PCL's Dividend Yield % or its related term are showing as below:
BKK:BKGI'
s Dividend Yield % Range Over the Past 10 Years
Min: 2.4 Med: 3.46 Max: 4.03
Current: 2.48
During the past 7 years, the highest Dividend Yield of Bangkok Genomics Innovation PCL was 4.03%. The lowest was 2.40%. And the median was 3.46%.
BKK:BKGI's Dividend Yield % is ranked better than 60% of 65
companies
in the Medical Diagnostics & Research industry
Industry Median: 1.9
vs BKK:BKGI: 2.48
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BKK:BKGI vs TMO, DHR, IDXX: Dividend Yield % Comparison
For the Diagnostics & Research subindustry, Bangkok Genomics Innovation PCL's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bangkok Genomics Innovation PCL Dividend Yield % vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Bangkok Genomics Innovation PCL's Dividend Yield % distribution charts can be found below:
* The bar in red indicates where Bangkok Genomics Innovation PCL's Dividend Yield % falls into.
Dividend Yield measures how much a company pays out in dividends each year relative to its share price.
Bangkok Genomics Innovation PCL Recent Full-Year* Dividend History
Amount
Ex-date
Record Date
Pay Date
Type
Frequency
Forex Rate
THB 0.050000
2026-05-06
2026-05-07
2026-05-28
Cash Dividend
annually
THB:THB 1.000000
* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bangkok Genomics Innovation PCL (BKK:BKGI) has a Dividend Yield % of 2.48% as of Jun. 28, 2026. Dividend yield is the ratio of company dividends to the share price. View historical data on Bangkok Genomics Innovation PCL and its competitors. This is 28% below median its historical median of 3.46. Over the past decade, Bangkok Genomics Innovation PCL's Dividend Yield % has ranged from 2.40 to 4.03. According to the industry distribution chart, Bangkok Genomics Innovation PCL ranks #26 out of 65 companies in the Medical Diagnostics & Research industry, placing it in the top 40%.
Is Bangkok Genomics Innovation PCL's Dividend Yield % too high?
Bangkok Genomics Innovation PCL's current Dividend Yield % of 2.48% is 28% below median its 10-year median of 3.46. Over the past 10 years, this metric has ranged from a low of 2.40 to a high of 4.03. The Medical Diagnostics & Research industry median Dividend Yield % is 1.90. Bangkok Genomics Innovation PCL's value of 2.48% is 30.5% above this industry median. Based on the distribution chart, Bangkok Genomics Innovation PCL ranks #26 out of 65 companies in the Medical Diagnostics & Research industry, which is above the industry midpoint. Overall, Bangkok Genomics Innovation PCL has a GF Score™ of 45/100, reflecting its overall financial health beyond just this single metric.
How does Bangkok Genomics Innovation PCL's Dividend Yield % compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Bangkok Genomics Innovation PCL ranks #26 out of 65 companies for Dividend Yield %. This puts Bangkok Genomics Innovation PCL in the upper half of its industry. The industry median Dividend Yield % is 1.90. Bangkok Genomics Innovation PCL's value of 2.48% is 30.5% above this benchmark. Historically, Bangkok Genomics Innovation PCL's own Dividend Yield % has ranged from 2.40 to 4.03 over the past decade. While the company's 10-year median is 3.46 vs. the industry median of 1.90, Bangkok Genomics Innovation PCL has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Yield % for a Medical Diagnostics & Research company?
The median Dividend Yield % among Medical Diagnostics & Research companies is 1.90, based on 65 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bangkok Genomics Innovation PCL's current Dividend Yield % of 2.48% is 30.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Yield % mean?
A high Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Dividend yield is the ratio of company dividends to the share price. View historical data on Bangkok Genomics Innovation PCL and its competitors. For the Medical Diagnostics & Research industry, the median Dividend Yield % is 1.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bangkok Genomics Innovation PCL's current Dividend Yield % is 2.48%, which is 28% below median its own 10-year median of 3.46. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bangkok Genomics Innovation PCL stock overvalued right now?
Bangkok Genomics Innovation PCL (BKK:BKGI) has a current Dividend Yield % of 2.48%. The current Dividend Yield % is 2.48%, which is 28% below median its 10-year median of 3.46 and 30.5% above the Medical Diagnostics & Research industry median of 1.90. Bangkok Genomics Innovation PCL's overall GF Score™ is 45/100 with 12 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Yield % calculated?
Dividend Yield % is calculated from a company's financial statements. For Bangkok Genomics Innovation PCL (BKK:BKGI), the current Dividend Yield % is 2.48% as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Bangkok Genomics Innovation PCL Business Description
Bangkok Genomics Innovation PCL operate a laboratory and provide medical analysis services. Its services includes Screening for genetic abnormalities in reproductive health (Reproductive Health Testing Services),Infectious Disease Analysis Product Group (Infectious - Related Testing Services), Other screening product groups (Other Testing Services), providing technology services (Tech Solution Services), and Sales of other medical products Related (Medical - Related Products). Its segments include Sale of laboratory reagents and related products; Testing and analysis services, which derives maximum revenue; and Sale and advanced therapy medicinal product.
45GF Score
Get the complete analysis for BKK:BKGI
Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:BKGI has been successfully added to your 
